Some of you know that I am in the second part of this Exceptional Responders study. There's some good and interesting news out of the first cohort.
"The findings from a recent study of patients with cancer who had an exceptional response to chemotherapy are yielding new clues on the molecular changes in patients’ tumors. These findings may explain the genetic alterations contributing to these patients’ dramatic and long-lasting responses to treatment—and could lead to achieving personalized treatment for more patients."